If India’s drug regulatory authority’s plan bears fruition, users will soon be able to report injuries and other problems caused by medical devices through a mobile app. The app will also list safety information and notify users if a particular product has been recalled.
此举是由11名成员组成的委员会在调查背景下，跨国制药公司Johnson和Johnson（J＆J）出售的有缺陷的髋关节植入物。为了维护依赖医疗设备的用户的利益，该小组在加强了其“材料宣传计划”以实施质量控制和监测标准方面宣布政府的意见。
CDSCO Registration Consultant For Medical Devices
When it comes to CDSCO medical device license process, Operon strategist makes the lengthy process easy and smooth with the best technical team working for you, along with excellent assistance, timely responses and affordable fees structure.
Read More WhatsAppTheDrugs Controller General of India(DCGI), S. Eswara Reddy, toldMintthat the regulator is of the opinion that the benefit-risk assessment of medical products can be tracked by letting users post feedback on the efficacy and potential side effects of such devices.
It is believed that around 4,700 surgeries were conducted across the country using faulty hip implants manufactured by J&J. Of these, 882 patients, accounting for 1,056 implants, have been identified. The minimum compensation to be paid to aggrieved patients has been pegged at Rs 20 lakh in the seven-year-old case.
India is not the only market wherearticulate surface replacement（ASR）由J＆J的子公司DePuy International生产的髋关节植入物引起了医疗并发症。
By creating a mechanism for redress, patients and healthcare professionals will be able to report instances where the use of medical devices has been counterproductive. By aggregating feedback, the DCGI hopes that a culture of greater transparency can be inculcated whereby the safety of patients will not be compromised.
The committee had suggested the establishment of an independent registry under the aegis of the health ministry totrack high-risk medical devices. If legal backing were to be accorded to such a body, manufacturers will be held accountable for the quality of their products. A registry will also help source performance metrics of medical devices and create an online network for users to share feedback.
In the hip-implant case, the committee tasked with bringing the manufacturer to the book, found that it was “evasive” in furnishing information regarding the design of the ASR.